Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Manisty, Charlotte; Otter, Ashley D; Treibel, Thomas A; McKnight, Aine; Altmann, Daniel M; Brooks, Timothy; Noursadeghi, Mahdad; Boyton, Rosemary J; Semper, Amanda; Moon, James C

doi:https://www.dx.doi.org/10.1016/S0140-6736(21)00501-8

File(s)

THELANCET-D-21-00833 R1. Clean version.12022021.docx (64.59 KB)

Accepted version

Author(s)

Manisty, Charlotte

Otter, Ashley D

Treibel, Thomas A

McKnight, Aine

Altmann, Daniel M

more

Type

Journal Article

Date Issued

2021-03-20

Date Acceptance

2021-02-01

Citation

The Lancet, 2021, 397 (10279), pp.1057-1058

URI

http://hdl.handle.net/10044/1/88153

URL

https://www.sciencedirect.com/science/article/pii/S0140673621005018?via%3Dihub

DOI

https://www.dx.doi.org/10.1016/S0140-6736(21)00501-8

ISSN

0140-6736

Publisher

Elsevier

Start Page

1057

End Page

1058

Journal / Book Title

The Lancet

Volume

397

Issue

10279

Copyright Statement

© 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/

License URL

http://creativecommons.org/licenses/by-nc-nd/4.0/

Sponsor

Medical Research Council (MRC)

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630397800014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Grant Number

MR/V036939/1

Subjects

Science & Technology

Life Sciences & Biomedicine

Medicine, General & Internal

General & Internal Medicine

Publication Status

Published

Date Publish Online

2021-02-25